Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Disorganization of the splenic microanatomy in ageing mice.

Aw D, Hilliard L, Nishikawa Y, Cadman ET, Lawrence RA, Palmer DB.

Immunology. 2016 May;148(1):92-101. doi: 10.1111/imm.12590. Epub 2016 Mar 17.

2.

Eosinophils are important for protection, immunoregulation and pathology during infection with nematode microfilariae.

Cadman ET, Thysse KA, Bearder S, Cheung AY, Johnston AC, Lee JJ, Lawrence RA.

PLoS Pathog. 2014 Mar 13;10(3):e1003988. doi: 10.1371/journal.ppat.1003988. eCollection 2014 Mar.

3.

Granulocytes: effector cells or immunomodulators in the immune response to helminth infection?

Cadman ET, Lawrence RA.

Parasite Immunol. 2010 Jan;32(1):1-19. doi: 10.1111/j.1365-3024.2009.01147.x. Review.

4.

Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice.

Ndungu FM, Cadman ET, Coulcher J, Nduati E, Couper E, Macdonald DW, Ng D, Langhorne J.

PLoS Pathog. 2009 Dec;5(12):e1000690. doi: 10.1371/journal.ppat.1000690. Epub 2009 Dec 11.

5.

Impact of continuous vigilance monitoring on nursing workflow.

Herdman TH, Burgess LP, Ebright PR, Paulson SS, Powell-Cope G, Hancock H, Wada E, Cadman EC.

J Nurs Adm. 2009 Mar;39(3):123-9. doi: 10.1097/NNA.0b013e31819894c8.

PMID:
19590468
6.

Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity.

Cadman ET, Abdallah AY, Voisine C, Sponaas AM, Corran P, Lamb T, Brown D, Ndungu F, Langhorne J.

Infect Immun. 2008 Sep;76(9):3924-31. doi: 10.1128/IAI.00372-08. Epub 2008 Jun 16.

7.

Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi.

Achtman AH, Stephens R, Cadman ET, Harrison V, Langhorne J.

Parasite Immunol. 2007 Sep;29(9):435-44.

8.

Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells.

Sponaas AM, Cadman ET, Voisine C, Harrison V, Boonstra A, O'Garra A, Langhorne J.

J Exp Med. 2006 Jun 12;203(6):1427-33. Epub 2006 Jun 5.

9.

The flood at the John A. Burns School of Medicine.

Cadman EC.

Hawaii Med J. 2005 Jan;64(1):22. No abstract available.

PMID:
15751757
10.

Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection.

Langhorne J, Albano FR, Hensmann M, Sanni L, Cadman E, Voisine C, Sponaas AM.

Immunol Rev. 2004 Oct;201:35-47. Review.

PMID:
15361231
11.

Changing emphases in public health and medical education in health care reform.

Patrick WK, Cadman EC.

Asia Pac J Public Health. 2002;14(1):35-9. Review.

PMID:
12597516
12.

Community refinement of glaucoma referrals.

Henson DB, Spencer AF, Harper R, Cadman EJ.

Eye (Lond). 2003 Jan;17(1):21-6.

PMID:
12579165
13.

Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center.

Balcezak TJ, Krumholz HM, Getnick GS, Vaccarino V, Lin ZQ, Cadman EC.

Am J Manag Care. 2000 Mar;6(3):329-38.

14.

A surplus of physicians? The view of internists at a single institution.

Balcezak TJ, Getnick GS, Cadman EC.

Conn Med. 1999 Dec;63(12):723-8.

PMID:
10659473
15.

An Internet-based law and medicine curriculum for residents.

Balcezak T, Lynch P, Cadman EC.

Acad Med. 1999 Oct;74(10):1053-4. No abstract available.

PMID:
10536621
16.

A web-based risk management and medical-legal curriculum for graduate medical education.

Balcezak TJ, Lynch P, Jackson S, Richter J, Jaffe CC, Cadman EC.

J Biocommun. 1998;25(4):2-5.

PMID:
9924687
17.
18.
19.

The presence of the complement cascade does not lead to neuronal cell death in primary hippocampal cultures.

Manelli AM, Cadman ED, Shiosaki K, Puttfarcken PS.

Brain Res Bull. 1997;42(3):187-93.

PMID:
8995328
20.

cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells.

Cadman ED, Naugles DD, Lee CM.

Neurosci Lett. 1994 Sep 12;178(2):251-4.

PMID:
7529912
21.

Regulation of the release of interleukin-6 from human astrocytoma cells.

Cadman ED, Witte DG, Lee CM.

J Neurochem. 1994 Sep;63(3):980-7.

PMID:
7519668
22.

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.

Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS, et al.

J Pharmacol Exp Ther. 1994 Jul;270(1):310-8.

PMID:
7518514
23.

The academic physician-investigator: a crisis not to be ignored.

Cadman EC.

Ann Intern Med. 1994 Mar 1;120(5):401-10.

PMID:
8304659
24.

Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.

Heimer R, Kaplan EH, Khoshnood K, Jariwala B, Cadman EC.

Am J Med. 1993 Aug;95(2):214-20.

PMID:
8356986
25.

Prevalence of HIV-infected syringes during a syringe-exchange program.

Heimer R, Kaplan EH, Cadman EC.

N Engl J Med. 1992 Dec 24;327(26):1883-4. No abstract available.

26.

Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors.

Garvey DS, Wasicak JT, Chung JY, Shue YK, Carrera GM, May PD, McKinney MM, Anderson D, Cadman E, Vella-Rountree L, et al.

J Med Chem. 1992 May 1;35(9):1550-7.

PMID:
1578480
27.

Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users.

Heimer R, Myers SS, Cadman EC, Kaplan EH.

J Infect Dis. 1992 Apr;165(4):781-2. No abstract available.

PMID:
1552214
28.

The new physician-scientist: a guide for the 1990s.

Cadman EC.

Clin Res. 1990 Apr;38(2):191-8. No abstract available.

PMID:
2338018
30.

Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.

Damon LE, Christensen S, Rochlitz C, Cadman EC.

Anticancer Res. 1989 Nov-Dec;9(6):1761-7.

PMID:
2534035
31.

Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate.

Damon LE, Cadman E, Benz C.

Pharmacol Ther. 1989;43(2):155-85. Review. No abstract available.

PMID:
2675132
32.

Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.

Prosnitz LR, Farber LR, Kapp DS, Scott J, Bertino JR, Fischer JJ, Cadman EC.

J Clin Oncol. 1988 Apr;6(4):603-12.

PMID:
2451712
33.

Cytotoxicity of ketoconazole in malignant cell lines.

Rochlitz CF, Damon LE, Russi MB, Geddes A, Cadman EC.

Cancer Chemother Pharmacol. 1988;21(4):319-22.

PMID:
3370740
34.

The metabolic basis for combination chemotherapy.

Damon LE, Cadman EC.

Pharmacol Ther. 1988;38(1):73-127. Review. No abstract available.

PMID:
3293090
35.
36.

High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.

Portlock CS, Fischer DS, Cadman E, Lundberg WB, Levy A, Bobrow S, Bertino JR, Farber L.

Cancer Treat Rep. 1987 Nov;71(11):1029-31.

PMID:
3677110
37.

Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.

Takimoto CH, Tan YY, Cadman EC, Armstrong RD.

Biochem Pharmacol. 1987 Oct 1;36(19):3243-8.

PMID:
2444230
38.

Combined total body electron beam irradiation and chemotherapy for mycosis fungoides.

Braverman IM, Yager NB, Chen M, Cadman EC, Hait WN, Maynard T.

J Am Acad Dermatol. 1987 Jan;16(1 Pt 1):45-60.

PMID:
3100583
39.

Involvement of a cytoplasmic protein in calcium-dependent potassium efflux in red blood cells.

Plishker GA, White PH, Cadman ED.

Am J Physiol. 1986 Oct;251(4 Pt 1):C535-40.

PMID:
3532815
40.

Who will determine the future of academic medicine?

Cadman E.

Clin Res. 1986 Sep;34(3):415-20. No abstract available.

PMID:
3757428
41.

Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease.

Jaffe HS, Cadman EC, Farber LR, Bertino JR.

Blood. 1986 Aug;68(2):562-4.

42.

Modulation of fluoropyrimidine metabolism by chlorpromazine.

Tseng A Jr, Brooks M, Cadman E.

Biochem Biophys Res Commun. 1986 Jul 31;138(2):1009-14.

PMID:
3741420
43.

Acute effect of 5-fluorouracil on cytoplasmic and nuclear dihydrofolate reductase messenger RNA metabolism.

Armstrong RD, Lewis M, Stern SG, Cadman EC.

J Biol Chem. 1986 Jun 5;261(16):7366-71.

PMID:
2423519
44.

Precursor-dependent differences in the incorporation of fluorouracil in RNA.

Takimoto CH, Cadman EC, Armstrong RD.

Mol Pharmacol. 1986 Jun;29(6):637-42.

PMID:
2940459
45.
46.

Fluoropyrimidine-mediated changes in small nuclear RNA.

Armstrong RD, Takimoto CH, Cadman EC.

J Biol Chem. 1986 Jan 5;261(1):21-4.

PMID:
3941072
47.

An analysis of 1539 patients with cancer of unknown primary site.

Altman E, Cadman E.

Cancer. 1986 Jan 1;57(1):120-4.

PMID:
3940611
48.

Drug-resistance genes can be spontaneously transferred among malignant cells.

Cadman E, Wong D, Liu E.

Prog Clin Biol Res. 1986;223:11-20. No abstract available.

PMID:
3809193
49.

Advances in rational combination chemotherapy.

Damon LE, Cadman EC.

Cancer Invest. 1986;4(5):421-44. Review.

PMID:
3542142
50.

Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.

DeGregorio MW, King OY, Holleran WM, Wilbur BJ, Cadman EC, Deisseroth AB, Wilbur JR.

Cancer Treat Rep. 1985 Dec;69(12):1441-2.

PMID:
4075318

Supplemental Content

Loading ...
Support Center